TrialDiabetes care2016

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial.

Vanita R Aroda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.